drugset / Trial / NCT05919381
Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the efficacy and safety of the combination of Gentuximab Injection and Paclitaxel Injection in patients with advanced gastric or gastroesophageal junction adenocarcinoma after first-line treatment failure compared with Placebo and Paclitaxel Injection.
Timeline
- Start
- 2022-05-30
- Primary completion
- 2024-12
- Completion
- 2025-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gentuximab | Monoclonal antibody | 8 mg/kg | Intravenous |